Breast CancerCancer
What this study is
RATIONALE: Collecting and storing samples of tissue, blood, and urine from patients with or without breast cancer to study in the laboratory may help the study of cancer.
PURPOSE: This research study is collecting and storing tissue samples from women with or without breast cancer.
What's being tested
- biologic sample preservation procedure
Intervention · OTHER
Tissue, urine and blood collection.
Study details
- Official title
- Breast Tissue/Body Fluids Repository
- Sponsor
- Vanderbilt-Ingram Cancer Center
- Conditions
- Breast Cancer
- Enrolling
- 4,000 people
- Starts
- 2004-01-22
- Est. completion
- 2027-03
- Record
- View on ClinicalTrials.gov ↗
Who can join
Age 18 Years and overSex FEMALEHealthy volunteers AcceptedYou may qualify if
- Breast lesion which is suspected to be cancer or a known diagnosis of breast cancer (any stage, at any point in the disease trajectory) who agrees to donate tissue/body fluids.
- Individuals of all races and ethnic groups are eligible for this trial. There is no restriction regarding age, race, or ethnicity. The trial is open to the accrual of men and women.
- Must sign informed consent for study of tumor specimens as part of a research project.
- Must give permission for their tumor specimens to be obtained from outside institutions for molecular analyses.
- Must be willing to be followed for recurrence, relapse and death from disease. ELIGIBILITY CRITERIA FOR OPTIONAL PHYSICAL FUNCTION AND COGNITIVE ASSESSMENTS
- Must be 60 years of age or older
- Have completed initial round of cancer treatment
- Have completed the optional online survey and opted-in for the physical function and cognitive assessments
Sign in and we'll check these against your records.Full criteria on ClinicalTrials.gov ↗
Loading treatment details…
1
Study locations (1)
1 openVanderbilt-Ingram Cancer Center
Nashville, Tennessee, United States
- Clinical Trials Office - Vanderbilt-Ingram Cancer Center · Contact800-811-8480
Recruiting
Study team
Sponsor
Vanderbilt-Ingram Cancer Center
Study ID VICC BRE 03103
Principal investigator
A. Bapsi Chakravarthy, MD
Vanderbilt-Ingram Cancer Center
Have questions? The contacts above can answer them before you apply.
Frequently asked questions
The sponsor hasn't published answers to common questions for this trial.